ASTS
AST SpaceMobile, Inc.
ASTS has lower modeled downside risk, despite its lower overall score.
GCTS
GCT Semiconductor Holding, Inc.
GCTS has the edge over ASTS overall, supported by stronger modeled upside.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
GCTS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Unavailable |
GCTS's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
GCTS PE Valuation
GCTS has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
GCTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect GCTS's revenue to grow, with its earnings and profitability holding steady. However, they disagree widely on these estimates.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS has the edge over GCTS on earnings, with more consistent year-over-year improvement.
GCTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.64 | +$0.17 |
| Q2 2026 | -$0.81 | -$0.09 |
| Q1 2026 | -$0.82 | -$0.34 |
| Q4 2025 | -$0.82 | -$0.52 |
GCTS lost $0.64 per share over the past year, a smaller loss than the year before.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over GCTS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS has the edge over GCTS on profitability, with a higher operating margin.
GCTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1M | +149% |
| Q2 2026 | $971K | -18% |
| Q1 2026 | $1.9M | +287% |
| Q4 2025 | $758K | -58% |
| Q3 2025 | $430K | -84% |
| Q2 2025 | $1.2M | -19% |
| Q1 2025 | $496K | -85% |
GCTS's revenue is recovering but still below its 2024 peak: $1M last quarter, up 149% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -690% | +1463 points |
| Q2 2026 | -764% | -121 points |
| Q1 2026 | -319% | +1241 points |
| Q4 2025 | -1577% | -1164 points |
| Q3 2025 | -2152% | -1926 points |
| Q2 2025 | -642% | -160 points |
| Q1 2025 | -1560% | -1782 points |
| Q4 2024 | -413% | N/A |
GCTS's operating margin was −690% last quarter, up 1462 points from the same quarter a year ago.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
GCTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$10.3M | -$2.5M |
| Q2 2026 | -$16.9M | -$8.1M |
| Q1 2026 | -$7.5M | +$575K |
| Q4 2025 | -$8.5M | -$5.9M |
| Q3 2025 | -$7.8M | -$3.1M |
GCTS has the edge over ASTS on cash flow, with more consistent year-over-year improvement.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has the edge over GCTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
GCTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +11% | +9.3M shares |
| 1 year | +78% | +40.2M shares |
GCTS has 92M diluted shares, up 78% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GCTS Net Leverage
GCTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
GCTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.6 | Neutral |
| Stochastic | 15.3 | Oversold |
GCTS's weekly RSI is 46 (neutral) and its Stochastic is 15 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
GCTS PE vs Technology Sector
GCTS has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over GCTS on trend strength, trading above more of its moving averages.
GCTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.65 | 6.7% below |
| 20 week MA | $1.92 | 20% below |
| 50 week MA | $1.73 | 11% below |
| 100 week MA | $1.68 | 8.3% below |
| 200 week MA | $4.98 | 69% below |
GCTS is in a downtrend: it's below all five of its weekly moving averages, and 69% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
GCTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $9.90 | $10.2 | +2.8% |
| 2023 | $10.2 | $10.6 | +3.7% |
| 2024 | $10.6 | $2.35 | -78% |
| 2025 | $2.35 | $1.22 | -48% |
| 2026 YTD | $1.22 | $1.54 | +26% |
GCTS has the edge over ASTS on returns for 2026, with the stronger performance.